CHLAMYDIAL INFECTIONS AND THE QUINOLONES

被引：8

作者：

RONALD, AR

PEELING, RW

机构：

[1] Department of Medical Microbiology, University of Manitoba, Winnipeg, R3E OW3, Manitoba, Room 543

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 1991年 / 10卷 / 04期

关键词：

D O I：

10.1007/BF01967010

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Some of the newer fluoroquinolones may be suitable agents for the treatment of Chlamydia trachomatis infections and non-gonococcal urethritis. To date, small studies with both ofloxacin and fleroxacin appear to achieve cure rates of 85-100% for urethritis and cervicitis due to Chlamydia trachomatis. However, large well-designed clinical trials are required to determine the efficacy and acceptance of these and other fluoroquinolones in the treatment of patients with genital or respiratory syndromes due to chlamydiae or other bacterial pathogens causing infections with similar manifestations.

引用

页码：351 / 354

页数：4

共 23 条

[11] EFFICACY OF OFLOXACIN IN THE TREATMENT OF NON-GONOCOCCAL URETHRITIS IN MEN AND GENITAL INFECTIONS CAUSED BY CHLAMYDIA-TRACHOMATIS IN MEN AND WOMEN [J].

NAYAGAM, AT ;

RIDGWAY, GL ;

ORIEL, JD .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 :155-158

[12]

OBATA I, 1989, REV INFECT DIS, V11, pS1281

[13]

ORIEL JD, 1989, REV INFECT DIS, V11, pS1273

[14]

POCIDALO JJ, 1989, REV INFECTIOUS DIS S, V11, P979

[15]

RIDGWAY GL, 1990, CHLAMYDIAL INFECTION, P531

[16]

SCHACHTER J, 1989, AM J MED S6C, V87, P14

[17] INVITRO ACTIVITY OF TOSUFLOXACIN (A-61827-T-3262) AGAINST SELECTED GENITAL PATHOGENS [J].

SEGRETI, J ;

HIRSCH, DJ ;

HARRIS, AA ;

KAPELL, KS ;

ORBACH, H ;

KESSLER, HA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (06) :971-973

[18]

SHEPARD MK, 1989, FERTIL STERIL, V52, P232

[19]

SOLTZSZOTS J, 1989, REV INFECT DIS, V11, pS1280

[20]

STAMM WE, 1990, CHLAMYDIAL INFECTION, P459

← 1 2 3 →